Literature DB >> 10708202

Acute isoniazid neurotoxicity during preventive therapy.

I Martinjak-Dvorsek1, V Gorjup, M Horvat, M Noc.   

Abstract

OBJECTIVE: To describe rare side effects of treatment with isoniazid.
DESIGN: Descriptive case report.
SETTING: Medical intensive care unit in a university medical center. PATIENT: A 14-yr old previously healthy girl receiving preventive isoniazid therapy who suddenly developed generalized tonic-clonic seizures and coma.
INTERVENTIONS: Patient was sedated and mechanically ventilated. She also received pyridoxine intravenously.
MEASUREMENTS AND MAIN RESULTS: An isoniazid overdose was not confirmed. Computed tomography of the brain and electroencephalogram revealed nothing abnormal. Seizures gradually disappeared within 2 hrs after sedation and treatment with pyridoxine. The patient was discharged on day 14 without consequences and has been well for 10 mos. No seizures reappeared after isoniazid was discontinued.
CONCLUSIONS: We caution against possible isoniazid neurotoxicity in healthy individuals using recommended preventive doses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708202     DOI: 10.1097/00003246-200002000-00047

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

1.  CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.

Authors:  Nicolas Vuilleumier; Michel F Rossier; Alberto Chiappe; Florence Degoumois; Pierre Dayer; Bernadette Mermillod; Laurent Nicod; Jules Desmeules; Denis Hochstrasser
Journal:  Eur J Clin Pharmacol       Date:  2006-04-27       Impact factor: 2.953

2.  The effects of isoniazid on hippocampal NMDA receptors: protective role of erdosteine.

Authors:  Ekrem Cicek; Recep Sutcu; Osman Gokalp; H Ramazan Yilmaz; M Kaya Ozer; Efkan Uz; Nurten Ozcelik; Namik Delibas
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

3.  Isoniazid overdose : a case series, literature review and survey of antidote availability.

Authors:  Graeme Maw; Peter Aitken
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.